TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Nattopharma AS
Closing information (x1000 NOK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover |
182,629
|
216,112
|
214,468 |
Financial expenses |
-148,526
|
970
|
-20,657 |
Earnings before taxes |
153,686
|
-11,551
|
44,054 |
Total assets |
274,657
|
228,995
|
255,687 |
Current assets |
201,574
|
128,328
|
125,503 |
Current liabilities |
179,331
|
74,831
|
66,382 |
Equity capital |
92,392
|
144,496
|
181,914 |
- share capital |
63,111
![]() |
63,111
|
59,530 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency |
33.6%
|
63.1%
|
71.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
84.2%
|
-5.3%
|
20.5% |
Return on assets (ROA) |
1.9%
|
-4.6%
|
9.2% |
Current ratio |
112.4%
|
171.5%
|
189.1% |
Return on equity (ROE) |
166.3%
|
-8.0%
|
24.2% |
Change turnover |
-33,483
|
1,644
|
83,318 |
Change turnover % |
-15%
|
1%
|
64% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.